Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,440,164
-
Share change
-
-3,420,418
-
Total reported value
-
$5,317,192
-
Price per share
-
$0.37
-
Number of holders
-
28
-
Value change
-
-$1,825,840
-
Number of buys
-
13
-
Number of sells
-
18
Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q3 2018
As of 30 Sep 2018,
AGILE THERAPEUTICS INC - COM (AGRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,440,164 shares.
The largest 10 holders included
ProQuest Associates IV LLC, INVESTOR AB, Vivo Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, Fosun International Ltd, ROYAL BANK OF CANADA, NEEDHAM INVESTMENT MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc..
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.